跳至主要内容
临床试验/NCT03635398
NCT03635398Unknown不适用

Intranasal Midazolam for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety Using sipNose Device - a Randomized Controlled Study

Rabin Medical Center1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
Sedation level

研究概览

简要总结

A Three-arm, Randomized Controlled Trial for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety: Intranasal Midazolam by SipNose versus MAD Versus oral administration

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • every child >1y who is intended for medical procedure in the emrgency room(suce as: IV insertion, blood sample collection, urinary catether insertion, laceration repair

排除标准

  • Active respiratory infection
  • systemic illness
  • Allergy to Midazolam

研究组 & 干预措施

Intranasal Midazolam by SipNose device

Experimental

干预措施: Sipnose device (Device)

Intranasal Midazolam by MAD (Mucosal Atomization Device)

Active Comparator

干预措施: MAD (Mucosal Atomization Device) (Device)

oral administration of midazolam

Active Comparator

干预措施: midazolam (Drug)

结局指标

主要结局

Sedation level

时间窗: within 60 minute

measured by RAMSAY SEDATION SCALE

Anexiety level

时间窗: within 60 minute

measured by modified PREOPERATIVE ANXIETY SCALE (YALE)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验